
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of over 400 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia, China and Korea. Founded in 2002, HMPs strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly and Nestl Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech, www.chi-med.com).
Pharmaceuticals;biotechnology;pharma;biotech;shanghai;china;research;development;drugs;botanicals;targeted therapies;nce;cancer;oncology;autoimmune disease;inflammation;ibd;lymphoma;tumors;kinase inhibitors
Hutchison medipharma's revenue is 11m - 100m
Hutchison medipharma has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.